VetPlus Synoquin EFA Large Breed Joint Support Tablets for Dogs Over 25kg | Glucosamine, Chondroitin & Krill Omega-3 | Cartilage Support, Joint Health & Mobility | 30 & 120 Tablets

For animal use. Administer as directed by a veterinarian or as per label instructions. Suitable for large breed dogs over 25kg.

VetPlus Synoquin EFA Large Breed Joint Support Tablets for Dogs (Over 25kg)

VetPlus Synoquin EFA is a veterinary nutraceutical joint supplement manufactured by VetPlus (UK), formulated with Glucosamine, Chondroitin, and Omega-3 Essential Fatty Acids (EFA) from a krill source, to support cartilage structure, joint health, and mobility in large breed dogs over 25kg. Widely used and recommended by veterinarians for long-term management of osteoarthritis, degenerative joint disease (DJD), and hip and elbow dysplasia in dogs. Krill-sourced Omega-3 EFA provides superior phospholipid-bound bioavailability compared to standard fish oil. Available in 30-tablet and 120-tablet packs; one tablet daily is the standard maintenance dose for most large breed dogs.

Composition (per tablet — confirm concentrations from product label)

• Glucosamine HCl — aminomonosaccharide; key precursor for glycosaminoglycan and proteoglycan synthesis in articular cartilage; supports cartilage structure and repair
• Chondroitin Sulphate — sulphated glycosaminoglycan; inhibits cartilage-degrading enzymes; supports water retention and elasticity of articular cartilage
• Omega-3 EFA (EPA & DHA) from Krill — anti-inflammatory via prostaglandin pathway modulation; krill phospholipid-bound Omega-3 has superior bioavailability vs fish oil triglycerides
• Concentrations per tablet — confirm from physical VetPlus Synoquin EFA Large Breed product label

Therapeutic Class

• Veterinary nutraceutical joint supplement for large breed dogs (over 25kg) — cartilage support, joint health, mobility, and osteoarthritis management

Key Benefits

• Glucosamine + Chondroitin — the two most evidence-supported nutraceutical actives for articular cartilage support; inhibit cartilage degradation and support proteoglycan synthesis
• Krill-source Omega-3 EFA — anti-inflammatory EPA/DHA; phospholipid-bound krill Omega-3 has superior absorption vs standard fish oil triglycerides
• Breed-size specific formulation — large breed dose optimised for dogs over 25kg; typically one tablet daily
• Long-term supplementation — suitable for daily ongoing use in OA, DJD, hip/elbow dysplasia, and post-surgical joint recovery
• 120-tablet pack — approximately 4-month supply for continuous management

Indications

• Osteoarthritis (OA) and degenerative joint disease (DJD) in large breed dogs
• Hip dysplasia and elbow dysplasia joint support
• Post-operative joint recovery and rehabilitation support
• Preventive joint support in large and giant breed dogs predisposed to OA
• Long-term joint health maintenance in active or senior large breed dogs

Directions for Use

• Administer orally as directed by a veterinarian or as per label instructions
• Standard maintenance dose: 1 tablet daily for large breed dogs over 25kg — can be given with or without food
• Loading phase: higher frequency for first 4–6 weeks may be recommended by veterinarian
• Allow 4–8 weeks of continuous supplementation for clinical benefit to become apparent; supplement long-term for best results

Safety Information

• For animal use only — keep out of reach of children
• Use with caution in dogs with known shellfish allergy (Glucosamine is shellfish-derived)
• Not a substitute for prescribed NSAID or analgesic therapy in moderate-to-severe OA — use as adjunct nutritional support under veterinary guidance
• Store in a cool, dry place away from direct sunlight; keep container tightly closed after use